Posted by AGORACOM-JC
at 11:50 AM on Tuesday, April 28th, 2020
(TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR)
Trusted and used by some of the world’s top professional sports teams, including:
Why Eyecarrot?
Eyecarrot Has Already Started Commercializing Its Vision Therapy Platform
Clients Include:
Dallas Stars (NHL)
Chicago Cubs (MLB)
Sporting KC (MLS)
Tennis Canada
Showcased During NFL Scouting Combine
Company’s Vision Therapy Products Used In:
Over 1,500 Practices
20 Countries
Flagship “Binovi” Is State-Of-The-Art Platform
Measures 14 Key Vision Skills
Essential For Maximizing Brain Performance
Shipped Over 400 Binovi Units (April 2020)
Goal Is 2,500 Binovi Units (End Of 2020)
Signed Sports Vision Partnership With Eli Wilson Goaltending
World Leader In Goaltending Development
600 Active Goaltending Camp Participants
50,000 Global Aspiring Goaltenders
Closed Major Financing In Q1 2020
Eyecarrot is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education
WHAT IS VISION THERAPY AND TRAINING?
1 in 4 people on the planet have vision problems that go beyond simply not being able to read those letters on the wall and requiring a prescription.
What your eyes see doesn’t always match up with what your brain sees. Eyecarrot synchronizes your eyes and your brain to deliver maximum performance for athletes and students.
The Company’s flagship product – Binovi – is a platform that measures 14 key vision skills essential for maximizing brain performance. Maximizing brain performance leads directly to making faster and better decisions, which directly correlates into an athlete or student’s best possible performance.
Result? Binovi delivers the performance edge everybody covets.
More than just words, Binovi is already being used by many professional sports teams and has been tested by more than 1,500 vision performance professionals in over 20 countries.
As a result, Binovi is quickly becoming an industry standard in the sports performance and vision rehabilitation markets.
SEEING IS BELIEVING!
Now that you have a baseline understanding of the power of Eyecarrot, the next thing to do is see it for yourself. Watch this videos of Eyecarrot and Binovi in action, with some really happy users.
Posted by AGORACOM-JC
at 7:18 AM on Monday, April 27th, 2020
Empower is utilizing clinic operations and tele-medicine to provide COVID-19 antibody testing to patients and consumers,
Establishes a four-phase nationwide rollout of Rapid COVID-19 testing and signs new COVID-19 test supply agreements
VANCOUVER, BC / April 27, 2020 /EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company”), a vertically integrated life sciences company is pleased to announce it has commenced COVID-19 antibody testing in its Sun Valley Health clinics in Phoenix, AZ using a blood draw test by clinic phlebotomists that are sent to an COVID-19 FDA approved laboratory partner. The laboratory submitted its request for FDA approval on March 16, 2020 under the Emergency Use Authorization (EUA).
“The Company has established a four-phase national COVID-19 testing program utilizing Rapid COVID-19 test kits”, said Steven McAuley, Chairman & CEO of Empower.
Phase One Testing in-clinics in Arizona, utilizing a patient blood draw by clinic phlebotomists, then samples are sent to our laboratory test partner for analysis, with test results expected within 48 hours.
Phase Two Offering a Rapid COVID-19 antibody test with results in 1-15 minutes. The service will be offered in-clinics using a drive-up service, conducted by Company clinic staff. In addition, an outbound door-step service, to support a variety of consumer, patient and community needs will be offered using certified mobile technicians. The Company anticipates phase two services will commence in May 2020.
Phase Three Business Employee Testing (BET) programs, offering Rapid COVID-19 testing to businesses on a one-time basis, repeat basis and/or subscription basis, to assist businesses to get back to work safely, will be offered. The Company anticipates phase three services will commence in May 2020.
Phase Four U.S. nationwide roll-out, offering all phases of Company services, that can be accessed online at Company websites and call centers, to purchase Rapid COVID-19 test kits. The Company anticipates phase four services to commence in Q3 2020.
Steven McAuley further states, “Our team are ready to meet the crisis head on, and we have ensured that the test processes and the test kits we use, are approved in the United States under the Emergency Use Authorization (EUA), as defined by the U.S. Food and Drug Administration (FDA).”
The Company has secured test kit supply agreements with two suppliers, NanoID Technologies Pty Ltd., that supply Zhuhai Livzon Diagnostics Inc. Rapid test kits, who made their test kit submission to the FDA on April 16th, 2020, and Emunah Trust, LLC, that supply Hangzhou TestSea Biotechnology Co., Ltd., Rapid test kits, who made their Rapid COVID-19 test kit submission to the FDA on April 16th, 2020.
CNN’s Dr. Sanjay Gupta explains what the science behind that testing means. Source: CNN
The World Health Organization, Director-General Dr. Tedros Adhanom Ghebreyesus has said, “Make no mistake: we have a long way to go. This virus will be with us for a long time. He has further stated, “We have a simple message for all counties: test, test, test.”
ABOUT EMPOWER
Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company now offers COVID-19 testing options and physician- based consultations, to address COVID-19 concerns.
For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond; the ability of the Company to complete or execute phases One, Two, Three or Four as noted above, and Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
Tags: CBD, CSE, Hemp, Marijuana, mental health, psilocybin, small cap Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Commences Corona Virus #Covid19 Antibody Testing and Establishes National Rollout Plan and Signs Supply Agreements for Rapid Covid-19 $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca
Posted by AGORACOM-JC
at 7:39 PM on Sunday, April 26th, 2020
CNBC Article mentions “Companies like Imagine AR (formerly Imagination Park Technologies Inc.) are already ahead of the curve in offering mobile based AR experiences, partnering with teams like the Sacramento Kings to create future AR offerings.“
 “Those are the technologies that have to be invested in and expanded by [teams] because they’ve got to fill the void for [lost attendance],†Miller said.
With games suspended, sports leagues will not only need to refund consumers, but also prepare for the future of sports ticketing due to the economic impact caused by Covid-19.
U.S. leagues have been on pause since March 11, when the NBA became the first to suspend games due to the coronavirus pandemic.
There is a bubble on the verge of bursting throughout sports leagues, adding to the already mounting problems facing an industry currently on pause due to the coronavirus pandemic. While leagues like the NBA, MLB and NHL have all suspended their seasons, a big bill could come due if they’re forced to outright cancel games, triggering a flood of calls from ticket holders for refunds. “It’s going be like what the airline and cruise lines are going through,†longtime sports exec Dr. Harvey Schiller told CNBC in an interview. “They are going have to come up with some general refund policy depending on the league.†The coronavirus is especially hurting the NBA and NHL, which are usually busy around this time as they gear up for playoff games and woo season ticket holders about renewal options for the next season. Clubs also lose the ability to continue tracking data from fans’ in-stadium spending habits and game day routines in an age of creating more personalized experiences in arenas. In a various conversations with team executives, who spoke to CNBC on condition of anonymity, some clubs have already refunded fans who requested it, while other teams are offering discounted prices for ticket packages once fans are allowed back. But teams will not be able to retain fans’ money too much longer. With unemployment skyrocketing, affecting more than 20 million people within the last month, more consumers will demand refunds, setting off phase one of what some in the sports industry said will be a period of revamping ticket monetization concepts after the pandemic is over. Schiller said teams would need to “get creative,†especially during a period of fan-free arenas, at least until new safety protocols are established and a coronavirus vaccine or treatment becomes available. And even when fans are allowed back in arenas, clubs won’t be able to offer ticket packages with just merchandise, food and beverage items included. Concepts for sporting events will have to change for a new generation of fans, while still retaining established customers. Suffering at the gate Schiller, the former president of the defunct NHL franchise, the Atlanta Thrashers, said it’s not unusual for teams to take out loans and use projected ticket sales as collateral, as clubs need funding to sustain operations throughout the year. More than likely, he said, those loans aren’t in jeopardy, as banks know sports teams are good for repaying. But until fans are allowed back in, organizations will need to find a way to make up game day dollars, which accounts for a substantial percentage of yearly revenue. According to one of the sports execs, the average gate receipt for a non-playoff NBA game is roughly $1 to $1.5 million. Last month, NBC Sports estimated the league could lose $500 million in ticket revenue when factoring in postseason games. According to a outlook report by accounting firm PricewaterhouseCoopers (PwC), gate revenue for the North American sports market grossed $19.2 billion in 2018, and is projected to increase to $21.8 billion in 2023. Marty Conway, a longtimesports marketing exec who developed digital and business strategies for organizations like AOL and the MLB’s Baltimore Orioles said he last estimated ticket revenue makes up roughly 36% of the NHL’s annual revenue, 30% of MLB’s and 22% of the NBA’s. Conway, an adjunct professor at Georgetown University’s McDonough School of Business, said the NBA and NHL are attempting to return not only for media dollars but “additional postseason ticketing revenues.†“Gate receipts are important; that’s real money,†added former CBS Sports president Neal Pilson, who predicted a limited return to sports this summer with so much still unknown about Covid-19. Ticketing 2.0 With ticket revenue at risk, team execs are already contemplating what the future of their sport will look like in a world with no or a limited number of fans at games, at least in the short-term. Many teams have added a variety of subscription packages to attract younger fans and those who avoid buying full-season packages, but that model needs another upgrade in the post-coronavirus world. Chris McGowan the CEO of Vulcan Sports and Entertainment, the company started by late Microsoft co-founder Paul Allen, said his team the Portland Trailblazers will “use this opportunity to look at every aspect of our entire operation.†“What are areas we need to improve, areas we need to change?†McGowan said. “We are having lots conversations about that.†McGowan added that “technology is going to be a big factor†in new ticket offerings. Mark Miller is the CEO of TicketSocket, a Newport Beach, California company that specializes in white labeling ticket solutions. Asked what new methods teams can adopt to help preserve ticket income, Miller suggested leagues get innovative about selling “single seats digitally†via virtual reality. The VR concept is one both the NBA and NHL has experimented with for several years, as the leagues seek to provide a better experience for at-home viewers. In 2019, the NHL partnered with tech company NextVR and Disney to enhance the VR experience, aiming to bring fans “closer to the on-ice action†and “make them feel like they are at a live NHL game,†according to a statement by Chris Golier, NHL vice president of business development. And in 2017, the MLB partnered with Intel to launch its VR experience. Leagues will need to enhance their platforms in hopes to entice customers, and now could be the opportunity leagues to invest in more augmented reality (AR) and VR experiences, a market projected to reach over $100 billion by 2025. Companies like Imagination Park Technologies Inc. are already ahead of the curve in offering mobile based AR experiences, partnering with teams like the Sacramento Kings to create future AR offerings. “Those are the technologies that have to be invested in and expanded by [teams] because they’ve got to fill the void for [lost attendance],†Miller said. Don White, the CEO of Satisfi Labs, an artificial intelligence management platform company, said tech firms are already studying “how to make your couch into this real premiere event until we can get back live audiences.†“It’s an expansion as opposed to a transition,†White said. “Ticketing is an important concept. I don’t think we should get away from ticketing in general because the ticket will also be your paid access. I think for sports, it’s important the ticket stays in the system.†The loss of on-site advertising dollars will also be an issue for some clubs. McGowan said the Blazers hadn’t experienced any significant pullback from ad partners with games on hold, but the team is in daily communication with companies as financial circumstances change. But even though companies are honoring partnerships, the structure of those agreements could look different .
Sports marketing post-Covid IEG, a consultancy that’s owned by Bruin Sports Capital, last week released a study estimating that $10 billion in sponsorship value in the U.S. could be disrupted by the sports and entertainment shutdown, with 20,000 sports and entertainment properties affected. The group said more than 5,000 brands are working through how to make up that value, while 120,000 active sponsorships have been impacted. The survey found that 62% of sponsors are re-evaluating their plans, while 20% are decreasing spending and 15% aren’t making changes yet. David Aburtyn, a partner at Bruin, said this doesn’t mean that $10 billion is lost, but that some new business could certainly be lost. Going forward, he said brands are thinking about how to do things in new, different ways. “That’s an area ripe for creativity and innovation,†Aburtyn said. One certainty we’ll see: Different timelines in the sponsorship world. Typically, sponsorships are planned far out, but some brands right now are thinking about what they can do in the much nearer-term, Aburtyn said. But fan-less events has an impact for sponsors, many of whom use sporting events to bring clients or prospects. “You don’t have an ability to host people and give them experiences — that stuff is very valuable as a sponsor,†said Dan Parise, SVP and managing director for Scout Sports & Entertainment, a division of Horizon Media. Parise said he hasn’t had any conversations about replicating that, say, with a video call with a client or prospect aligning with the event. “There’s a little bit lost on the impact of face-to-face,†when communicating via video instead of in-person, he said. Right now with so much uncertainty about the months ahead, the tenor of business seems to have cooled. Scout’s Parise said there doesn’t appear to be an overwhelming desire to buy sponsorships right now. And existing sponsors are thinking through a litany of contingencies. “I think existing sponsors are trying to think about the various contingencies that they could have — if baseball happens in this way, how do I shift my activation strategy? If it happens with fans, without fans?†Parise said. Potential sponsors might also be struggling themselves. “There are a lot of businesses that are hurting,†Parise said. “It’s harder for the sales folks to be out there pounding the pavement to find new sponsors; they don’t want to be seen as insensitive during this time.†So much is in flux, but fanless sports might throw the financials of the whole sports ticketing and marketing world off kilter. “The economics are so cranked up, and they’re cranked up because of media advertising and gate receipts,†said Dave Morgan, founder and CEO of Simulmedia and longtime media industry executive. “If you take away the gate receipts, media advertising can’t spend more, and media advertising depends a lot on a physical venue and a physical integration with the fans. So I would say, sports without fans takes a huge part of the value component that makes the economics work. And the question will be, out of whose pocket will this come?†Source: https://www.cnbc.com/2020/04/24/sports-ticketing-will-look-different-as-teams-get-creative-without-fans.html?utm_content=127744186&utm_medium=social&utm_source=linkedin&hss_channel=lcp-10871904
Posted by AGORACOM-JC
at 2:44 PM on Friday, April 24th, 2020
Secured vendors and accepted proposals from third-party laboratories to further its lithium metallurgical processing technology’s advanced bench testing and its pilot plant
Up to recently, the Company had strategically divided the research workload between various laboratories to protect the intellectual property being developed
These segmented R&D silos will now come together and be integrated within the pilot plant operations
Montreal – April 24, 2020 – St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE: 85G1) is pleased to announce that it has secured vendors and accepted proposals from third-party laboratories to further its lithium metallurgical processing technology’s advanced bench testing and its pilot plant.
Up to recently, the Company had strategically divided the research workload between various laboratories to protect the intellectual property being developed. These segmented R&D silos will now come together and be integrated within the pilot plant operations.
As previously announced on February 10, 2020, in the “Winter Update” press release, the Company expected to secure an agreement within the second quarter of 2020. The use of ready-made facilities will generate significant cost reductions and represent a faster alternative than the building of a pilot plant from scratch. St-Georges’ management evaluated different proposals from various potential providers that were intended to meet the Company’s requirements.
The main contractor retained tipped the balance in its favor with a wealth of experience and state-of-the-art, ready-made facilities that only required certain adjustments specific to the St-Georges process. The team expects an adjustment period, and plant trial runs during Q2 and Q3 2020, subject to Quebec COVID-19 confinement releases. Full pilot scale testing should be initiated in or around the beginning of this year Q4.
The Company is expecting to receive materials from Iconic Minerals Ltd. (TSX-V: ICM) in accordance with the next phase of the on-going research and development program in place with the Company. Discussions are being held with various mines operators and mineral developers. Producers of spodumene concentrate have shown interest in supplying material for testing.
Quebec Lithium Resources
St-Georges also sourced material from a Quebec-based lithium project. The Company’s contractors will be preparing 10 to 15 tonnes of material that should yield results of approximately three metric tonnes of industry-grade spodumene concentrate suitable for pilot testing with the St-Georges’ process. The material should be available to the metallurgical team in the weeks following the Quebec government’s lifting of the COVID-19 lock-down. Sourcing local Quebec material qualifies the Company to apply for certain governmental grants, and the Company expects to apply for these grants in 2020.
Enrico Di Cesare, President of St-Georges Metallurgy Corp., commented: “Our partners’ facilities seem built for St-Georges. Under the circumstances, it would be non-sensical to spend time and money to replicate the facilities that they own. These groups have significant experience with concentrating, acids and solutions we will be using. In addition, it de-risks St-Georges by allowing us to focus on development work that is on-going. St-Georges looks forward to working with all our partners at CTMP (Centre de Technologie Minerale et de Plasturgie inc.), which has performed the early development work and will continue to work with the St-Georges team. We feel we will be able to accelerate the development and eventual market acceptance of the products we intend to produce. We believe this combination of laboratory work at bench scale and eventual large-scale pilot plant operations will accelerate our development work. We feel blessed to have two quality partners to move forward with, and we continue our collaborations with universities that specialize in this field of work.“
St-Georges Metallurgy Corp.
On February 27, 2020, St-Georges incorporated a new subsidiary, St-Georges Metallurgy Corp., and appointed Enrico Di Cesare as its President and CEO. This entity is owned 100% by St-Georges and will handle all metallurgical R&D, laboratory partnerships, metallurgical joint ventures, and related intellectual property.
In April, the Company has secured the services of a veteran metallurgist, Mr. Ian J. Cox, to work on the projects with a focus on both lithium and nickel
Ian has a degree in fuel and combustion science, from Leeds University, UK. With post-grad courses in project management from the University of Tennessee, leadership from Harvard, and finance from the Massachusetts Institute of Technology (MIT), he is an experienced project manager/process engineer with extensive experience in new process development and transition from development to design and operation. Ian has built a profitable business in highly competitive international markets. He builds strong multi-function teams with international joint venture/partnering experience.
Iceland Exploration Update
The previously announced work programs in Iceland (See September 3 2019 Press Release), were not finished due to extreme weather conditions. With the arrival of spring and the Icelandic government allowing people to circulate for work as the COVID-19 confinement directives are being eased, the Company expects to be able to finish its Thor sampling program and send those samples to Canada for processing in May, with Vopna and Troll to follow in June-July. No resolution has yet materialized in regard to drilling the Thor property. Management expects to be able to drill this summer, but no certainty can be given in that regard.
Covid-19 Impacts Assessment
The Covid-19 pandemic impacts all of the Company’s Quebec operations. Quebec North-Shore exploration operations are halted until further notice from the government. The Company is using this period to prepare its intervention plan to meet with the First Nations on whose ancestral territory the projects lie. The current process requires 60 to 90 days to receive the relevant permits. It is currently impossible to know when this process will be initiated.
ON BEHALF OF THE BOARD OF DIRECTORS
“Vilhjalmur Thor Vilhjalmsson”
Vilhjalmur Thor Vilhjalmsson
President and CEO
About St-Georges
St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry.
The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
Posted by AGORACOM-JC
at 1:21 PM on Wednesday, April 22nd, 2020
SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.
Tiredness could be ‘human signature’ used to detect bots on Twitter
Concerns about the impact of deceptive bot networks spreading disinformation in order to influence democratic events, such as the 2016 US presidential election, had lead to calls from lawmakers, academics and campaigners for social media companies to detect and take down these networks
These efforts will include human moderators and machine learning algorithms trained to detect suspicious behaviour
By E&T editorial staff
A study has identified short-term behavioural differences between humans and bots – reflecting what is likely to be increasing tiredness towards the end of a social media session – which could be used to detect and take down networks of bots on social media.
Bots – which are controlled by computers, rather than by humans – serve a wide variety of purposes, including news aggregation and customer service. Despite their benefits, bots have come under scrutiny recently in the context of being used manipulatively as part of large-scale, state-backed projects to spread disinformation on social media platforms.
Concerns about the impact of deceptive bot networks spreading disinformation in order to influence democratic events, such as the 2016 US presidential election, had lead to calls from lawmakers, academics and campaigners for social media companies to detect and take down these networks. These efforts will include human moderators and machine learning algorithms trained to detect suspicious behaviour.
Now, a first-of-its-kind study published in Frontiers in Physics has identified some short-term behavioural trends seen in human-run accounts which are absent in bot accounts. This could provide a “human signature†to detect fake accounts, which are constantly adapting to fool detectors.
“Remarkably, bots continuously improve to mimic more and more of the behaviour humans typically exhibit on social media,†said Professor Emilio Ferrara, a University of Southern California computer science expert and co-author of the study. “Every time we identify a characteristic we think is prerogative of human behaviour, such as sentiment of topics of interest, we soon discover that newly developed open-source bots can now capture those aspects.
Ferrara and his colleagues studied how the behaviour of humans and bots changed over the course of single sessions using a large Twitter dataset associated with recent political discussion. They monitored factors such as propensity to engage in various social interactions and volume and type of tweets they wrote, then compared the results between humans and bots.
They found that humans showed an increase in the amount of social interaction over the course of a session (an increase in the fraction of retweets, replies and mentions in a tweet) and a decrease in the amount of content they produce (a decrease in average tweet length). The researchers suggested that this could reflect humans becoming tired towards the end of the session and being less able or willing to produce original content. This behavioural change was not seen in bots.
The researchers used these results to inform a classification system for bot detection. They found that their model significantly outperformed a baseline model in its bot-detection accuracy, indicating that searching for short-term behavioural patterns like this could be valuable in the implementation and improvement of detection systems.
“Bots are constantly evolving: with fast-paced advances in AI, it’s possible to create ever-increasingly realistic bots that can mimic more and more how we talk and interact in online platforms,†said Ferrara. “We are continuously trying to identify dimensions that are particular to the behaviour of humans on social media that can in turn be used to develop more sophisticated toolkits to detect bots.â€
Posted by AGORACOM-JC
at 7:20 AM on Wednesday, April 22nd, 2020
Empower is utilizing clinics, physicians, technology and direct access to 165,000 patients to launch dedicated division and resources for psilocybin research.
Created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder and addiction
“Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower
VANCOUVER, BC / April 22, 2020 /EMPOWER CLINICS INC. (CSE: CBDT)(OTC: EPWCF)(Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented life sciences company is pleased to announce, it is has created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder (PTSD) and addiction.
The Company is leveraging its assets that include the existing clinic network, the developing franchise brand, tele-medicine, access to its 165,000 patients and large physician team, to make advancements in psilocybin research and psychedelics therapy in general.
“Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower. “Clinical trials continue to show that psilocybin therapies may provide tremendous help with these conditions, that we see every day in our clinics. As a Company, we must endeavour to utilize our assets and capabilities to positively impact patients’ lives.”
The mental health crisis could cost the world $16 trillion by 2030 according to Future Market Insights and further, the global behavioral health (non-pharmacological) market is expected to be valued at US$156 billion by 2028.
According to the World Health Organization (WHO), depression is the leading cause of disability worldwide, and it is a major contributor to the overall global burden of disease.
The United States Food and Drug Administration has determined that preliminary clinical evidence indicates psilocybin may demonstrate substantial improvement over other available therapies for treatment-resistant depression; and granted a Breakthrough Therapy designation for a treatment that uses psilocybin as a therapy for such depression.
ABOUT EMPOWER
Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.
For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.
Tags: CBD, CSE, Hemp, Marijuana, mental health, psilocybin, small cap, stocks Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Continues to Advance Development of #Psilocybin and Psychedelics Division to Address Significant Mental Health Issues $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca
Posted by AGORACOM-JC
at 4:29 PM on Tuesday, April 21st, 2020
When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years to help them detect social media disinformation about COVID-19, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world. Â
But when the Canadian government calls on you to help with the import and sale of COVID-19 test kits from South Korea, it is also safe to assume your trust and security clearances are at the highest levels possible.  Â
You would probably also assume such a company to be a tech giant or a Silicon Valley funded startup. But Datametrex AI (DM: TSXV) is neither. Rather, it is a great Canadian small cap technology company who happens to have: Â
“developed strong relationships with many large multi-national companies in South Korea. As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.”
If that wasn’t enough, Datametrex has also achieved the following as of late:
Q3 Revenues Of $1.6 million, an increase of 186%
9 Month Revenues Of $2.56M an increase of 37%
Repeat Contracts Of $1M and $600,000 With Korean Giant LOTTE
$954,000 Contract With Canadian Department of Defence To Fight Social Media Election Meddling
Participation In NATO Research Task Group On Social Media Threat Detection
Becoming an affiliate member of the Carnegie Mellon University Center for IDeaS
When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, as well as, being called upon by the Canadian federal government to ask for help with the greatest pandemic in 100 years, smart small cap investors are compelled to take a closer look. Â
That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who discusses obtaining the rights to import and sell COVID-19 test kits from South Korea and the impact it will have on the Company. Â
Watch this interview on one of your favourite screens or hit play and listen to the audio as you drive.Â
Posted by AGORACOM-JC
at 7:12 AM on Tuesday, April 21st, 2020
Provides additional specifics on the previously announced news release regarding acquiring the rights to import COVID-19 test kits from South Korea
An application for approval was made to Health Canada under the Fast-Track program on April 9th, 2020
As part of the submission, the Company has submitted a Medical Devices Interim Order Request Form under Interim Order
Interim Order (IO) will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada
TORONTO, April 21, 2020 — Datametrex AI Limited(the “Company†or “Datametrexâ€) (TSXV: DM, FSE: D4G, OTC:DTMXF ) wishes to provide additional specifics on the previously announced news release regarding acquiring the rights to import COVID-19 test kits from South Korea. An application for approval was made to Health Canada under the Fast-Track program on April 9th, 2020.
As part of the submission, the Company has submitted a Medical Devices Interim Order Request Form under Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on March 18, 2020. This Interim Order (IO) will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada.
The Company has represented to Health Canada that it will be able to provide a minimum first order of 200,000 units, followed by an additional 100,000 units on a weekly basis. Any purchase of the test kits by the Canadian government is conditional on prior receipt of Health Canada approval. Datametrex is currently working with Dr. Lisa Palleson-Stallan and Dr. Joseph Curtis to assist with obtaining Health Canada approval, and each has agreed to join the Company’s advisory board.
Dr. Joseph Curtis is the Chief Scientific Officer and founder of BioQuant Laboratories (BQL) an independent testing laboratory providing analytical testing services to firms across the U.S. and Canada developing natural product medicines for human and animal health. Dr. Curtis has twenty-five years of experience across and has held various executive positions within public and private sector firms. Working across the public health emergency medical countermeasures continuum, he supported the USA’s blood and tissue preparedness and response programs managed by the American Red Cross. In this capacity, he served as the Director, Biomedical Headquarters Facility Quality Assurance coordinating performance excellence programs across a nation-wide network of manufacturing and testing facilities delivering $2 billion of cellular therapies and transfusion medicine products to over 3,000 hospitals across the US.
Dr. Lisa Palleson-Stallan obtained her Ph.D in International Business with Honours in the U.K. She ran a European Union funded project on technology and Innovation and completed post doctoral work at the World Health Organization (WHO) publishing on Tobacco Cessation. She created her first retail company, Lotuswear, which grew into a 100 employee + company and had the role as presidentand CEO. She became an early adopter in several industries and has continued building value from the ground up. She has built a successful consultancy company that targets the Asian marketplace within the Health space. Dr Palleson-Stallan has been given role and title of Global Health Advisor to assist the Chinese Government with unconditional support and authority to conduct negotiations regarding how to best to combat the spread of Covid-19.
“We are thrilled to be in a position to bring high quality test kits to Canada to help flatten the curve and save lives. We are doing everything we can to provide Health Canada with the required information to move forward. We are looking forward to solving these problems alongside Dr. Palleson-Stallan and Dr. Curtis.â€, says Marshall Gunter, CEO of the Company.
Datametrex anticipates that it will have little or no upfront costs associated with importing these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.
About Datametrex AI Limited
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Additional information on Datametrex is available at www.datametrex.com
For further information, please contact:
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Jeff Stevens – Co-Founder Phone: (647) 400-8494 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 5:34 PM on Monday, April 20th, 2020
SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation Click here for more info.
80% of Americans believe they read coronavirus “fake news†in the early stages of the epidemic
A Pew survey of 8,914 US adults found that 4 in 5 Americans believe they were misled by the media about the coronavirus situation
About half of the participants gave examples of this misinformation, and at least a part of it wasn’t actually fake news
We’ve been covering the COVID-19 pandemic since January, when it was still a “mysterious virus in Wuhanâ€. Like everyone else, we didn’t know what to make of it at first — and we were shocked to see how quickly and dramatically the situation developed.
We did our best to cover the available information accurately, but we noticed something weird happening in the comment section and the emails we were getting. A lot of people were upset with our coverage and felt like we weren’t communicating the threat properly — about half of the complaints were saying we were exaggerating the risks. The other half claimed we weren’t explaining the risks enough. Source: Pew Research Center.
A similar feeling seems to be reported in much of the American population. The largest group of responses in the Pew survey (41% of all who provided claims) felt they were misled about the level of risk. The sentiment was divided into two roughly equal sides: 22% felt the information falsely elevated the risk, while 15% felt it downplayed the risk. In particular, people in the latter group cited not only the media but also the administration and the president, who promised an early end to the problem and repeatedly underplayed the risks posed by the coronavirus.
It’s safe to say that President Trump’s intervention has been a major contributor to misinformation, as he repeatedly came out saying that the coronavirus is less dangerous than the flu. But this statement was also found in several media outlets. Just as the administration fumbled its response on multiple levels, so, too, did the media by taking too long in communicating a clear message about the coronavirus situation.
It was only on March 15 when the CDC told the country to stop gathering in groups, and at the time, the virus was already spreading in the US. The government also urged people not to buy any type of face masks, but then changed its recommendation, causing even more confusion.
Americans’ opinions are also mixed about how much misinformation they have seen. According to the Pew survey, 12% believe they’ve seen “a lotâ€, and 20% believe they’ve seen “none at allâ€, with the rest stating that they’ve seen “some†or “not much†misinformation.
Posted by AGORACOM-JC
at 8:47 AM on Monday, April 20th, 2020
Announced a multi-year partnership with Eli Wilson Goaltending, a world leader in goaltending development, goaltending camps, and clinics
Eli Wilson has established himself as one of the premier goaltending coaches in the world through his work with dozens of goaltenders in the National Hockey League (NHL) and Team Canada
Toronto, New York -Â April 20th, 2020 – Eyecarrot Innovations Corp., (Eyecarrot) (TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR) is excited to announce a multi-year partnership with Eli Wilson Goaltending, a world leader in goaltending development, goaltending camps, and clinics. Eli Wilson has established himself as one of the premier goaltending coaches in the world through his work with dozens of goaltenders in the National Hockey League (NHL) and Team Canada. The partnership will provide Eli Wilson Goaltending camps with the Binovi Touch neurovision sports training hardware, alongside screen-based resources for athletes to support their development on and off the ice. The Eli Wilson Goaltending partnership will ultimately expose 600 active goaltending camp participants, aged 10 to 19 years and a global network of over 50,000 aspiring goaltending athletes to Eyecarrot’s Binovi Sport Vision Platform for off-ice training. As many nations continue to practice social distancing during COVID-19 and post pandemic, the Binovi Sports Vision Platform offers accessible turnkey athletic resources in step with subscription-based home fitness solutions Tonal, Peloton (PTON: NASDAQ) and Mirror. A subscription structure will support the company’s global product scaling strategy and “at-home” consumer offerings.
“I emphatically believe the best way to develop goaltenders is by teaching a system within a system. Quality drills, attention to detail, repetition and simplicity are major factors in building successful goaltenders. The goaltender must learn needed skills in a progressive manner in a controlled environment. With Binovi, we are gaining a sports vision training system to improve vision in that same controlled way, ensuring proper analysis and progress,” commented Eli Wilson, Eli Wilson Goaltending Founder, CEO
Under his tutelage, Eli’s camps –which see over 600 athletes annually– have produced more than 50 NHL draft picks, over 60 Division I, Canadian University goaltenders, and more than 200 players drafted by Major Junior teams. His goaltenders have gone on to win numerous prestigious awards and championships, including the Stanley Cup, Conn Smythe Trophy, Vezina Trophy, World Junior Gold Medals, American Hockey League (AHL) championships, AHL Playoff MVPs, Western Hockey League (WHL) Goaltender of the Year awards, Ontario Hockey League (OHL) Goaltender of the Year awards, and Canadian Hockey League (CHL) Goaltender of the Year awards. In addition to standard camp programming, Eli has introduced a number of specialty camps, including the popular 24/7 camp, where goaltenders actually live and train with Eli over a three-day weekend. A main staple of Eli’s year-round training is advanced video technology, whereby he and his staff can analyze video remotely to further goaltending development.
This strategic partnership will support Eyecarrot’s aggressive positioning of its sports vision performance offerings in the sport of hockey through an increased presence in key hockey development programs including direct NHL team alignments. Hockey, a leading sport in Canada, will benefit from big-tech partnerships of this nature that are designed to enhance athlete performance at all development levels of the sport.
“We’re very excited to be working with an athletic training team that clearly has a very high drive for success, and such an incredible track record for turning out exceptional players. Our goal is to see Binovi boost the performance of athletes going through these camps and training regimens. After all, competition is what drives sport, and any edge players and their training teams can get to get that competitive edge over an opponent is key. We look forward to working alongside Eli and his team as we continue to develop Binovi for sports,” stated Adam Cegielski, President and CEO.
Click here for more information on Binovi Sports Vision Training.
About Eli Wilson Goaltending
Eli Wilson has worked with over 30 NHL goalies (and counting) to sharpen all essential goaltending skills, including mental conditioning and off-ice training. Eli’s programs help to hone an athlete’s reflexes and improve agility in the net. The camp experience mirrors how Pro and NHL goaltenders’ practice, train, think, and act, to get to the top of their game. In 2004, Eli was named to Hockey Canada’s goaltending consultant group. He has consulted with Creative Artists Agency (CAA) Sports during their summer development camps for top young prospects in Los Angeles, California. Eli has also traveled to South Korea to work with the Kangwon Land Ice Hockey team and other young goaltenders in the country. From 2007 through 2010, Eli was the goaltending coach for the Ottawa Senators, where he was responsible for the Ottawa Senators goaltenders as well as for the goalies playing for their AHL affiliate, the Binghamton Senators. Established in 2010, the Eli Wilson Goaltending program sees over 600 athletes every year and helps give them the competitive edge to set themselves apart in a very challenging and exclusive club.
About the NHL
The National Hockey League (NHL(R)), founded in 1917, consists of 31 Member Clubs, each reflecting the League’s international makeup with players from more than 20 countries represented on team rosters, vying for the most cherished and historic trophy in professional sports – the Stanley Cup(R). Every year, the NHL entertains more than 670 million fans in-arena and through its partners on national television and radio; more than 151 million followers – league, team and player accounts combined – across Facebook, Twitter, Instagram, Snapchat and YouTube; and more than 100 million fans online at NHL.com. The League broadcasts games in more than 160 countries and territories through its rightsholders including NBC/NBCSN and the NHL Network(TM) in the U.S., Sportsnet and TVA in Canada, Viasat in the Nordic Region and CCTV and Tencent in China. The NHL reaches fans worldwide with games available online in every country including via its live and on-demand streaming service NHL.TV(TM). Fans are engaged across the League’s digital assets on mobile devices via the free NHL(R) App; across nine social media platforms; on SiriusXM NHL Network Radio(TM); and on NHL.com, available in eight languages and featuring unprecedented access to player and team statistics as well as every regular-season and playoff game box score dating back to the League’s inception, powered by SAP. The NHL is committed to building healthy and vibrant communities through the sport of hockey by increasing youth participation and engagement; fostering positive family experiences; promoting inclusion, positive culture and leadership; and supporting sustainable community impact.
About Eyecarrot Innovations Corp
Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.
Adam Cegielski
President | CEO
Tania Archer
Head of Global Marketing | Sales | Strategic Partnerships
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Source: Pew Research Center.